Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation

被引:67
作者
Mohty, Mohamad [1 ]
Labopin, Myriam [2 ,3 ]
Tabrizzi, Reza [4 ]
Theorin, Niklas [5 ]
Fauser, Axel A. [6 ]
Rambaldi, Alessandro [7 ]
Maertens, Johan [8 ]
Slavin, Shimon [9 ]
Majolino, Ignazio [10 ]
Nagler, Arnon [11 ]
Blaise, Didier [12 ]
Rocha, Vanderson [2 ,3 ,13 ]
机构
[1] Univ Nantes, CHU Hotel Dieu, Serv Hematol Clin, Pl Alexis Ricordeau, F-44093 Nantes, France
[2] Hop St Antoine, AP HP, European Grp Blood & Marrow Transplantat EBMT, Acute Leukemia Working Party, Paris, France
[3] Univ Paris 06, Pierre & Marie Curie, Paris, France
[4] CHU Bordeaux, Hop Haut Leveque, Pessac, France
[5] Univ Hosp, Dept Hematol, Linkoping, Sweden
[6] Klin Knochenmarktransplantat & Haematol Onkol, Idar Oberstein, Germany
[7] Osped Bergamo, Div Ematol, Bergamo, Italy
[8] Univ Hosp Gasthuisberg, Dept Hematol, Leuven, Belgium
[9] Hadassah Univ Hosp, Dept Bone Marrow Transplantat, Jerusalem, Israel
[10] Osped S Camillo Forlanini, Dept Hematol & BMT, Rome, Italy
[11] Tel Aviv Univ, Chaim Sheba Med Ctr, Tel Hashomer, Israel
[12] Inst Paoli Calmettes, Unite Transplantat & Therapie Cellulaire, Marseille, France
[13] Hop St Louis, AP HP, Dept Hematol, Paris, France
关键词
allogeneic SCT; acute lymphoblastic leukemia;
D O I
10.3324/haematol.11960
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This retrospective study reported the outcome of 97 adult acute lymphoblastic leukemia patients who received a reduced-intensity conditioning allogeneic stem cell transplantation. With a median follow-up of 2.8 years, two year overall-survival, leukemia-free survival and non-relapse mortality were significantly better in patients transplanted in first complete remission (CR1, 52 +/- 9%; 42 +/- 10%; and 18 +/- 7% respectively) compared with those transplanted in more advanced phase (p=0.003, p=0.002 and p=0.01 respectively). In multivariate analysis, disease status (CR1 vs. advanced; p=0.001) and chronic graft-vs-host disease (p=0.01) were associated with an improved overall-survival, suggesting that reduced-intensity conditioning allogeneic stem cell transplantation is feasible in patients with high risk lymphoblastic leukemia in remission at transplantation.
引用
收藏
页码:303 / 306
页数:4
相关论文
共 50 条
  • [21] Outcome of T-cell-replete haploidentical stem cell transplantation improves with time in adults with acute lymphoblastic leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Nagler, Arnon
    Labopin, Myriam
    Koc, Yener
    Angelucci, Emanuele
    Tischer, Johanna
    Arat, Mutlu
    Pioltelli, Pietro
    Bernasconi, Paolo
    Chiusolo, Patrizia
    Diez-Martin, J. L.
    Sanz, Jamie
    Ciceri, Fabio
    Peric, Zinaida
    Giebel, Sebastian
    Canaani, Jonathan
    Mohty, Mohamad
    CANCER, 2021, 127 (14) : 2507 - 2514
  • [22] Localized relapse in bone marrow of extremities after allogeneic stem cell transplantation for acute lymphoblastic leukemia
    Endo, T
    Sato, N
    Koizumi, K
    Nishio, M
    Fujimoto, K
    Sakai, T
    Kumano, K
    Obara, M
    Minauchi, K
    Koike, T
    AMERICAN JOURNAL OF HEMATOLOGY, 2004, 76 (03) : 279 - 282
  • [23] Allogeneic Hematopoietic Cell Transplantation with Full-Intensity Conditioning for Adult Acute Lymphoblastic Leukemia: Results from a Single Center, 1998-2006
    Doney, Kristine
    Gooley, Ted A.
    Deeg, H. Joachim
    Flowers, Mary E. D.
    Storb, Rainer
    Appelbaum, Frederick R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (08) : 1187 - 1195
  • [24] Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
    Sebastian Giebel
    Ariane Boumendil
    Myriam Labopin
    Anouchka Seesaghur
    Frederic Baron
    Fabio Ciceri
    Jordi Esteve
    Norbert-Claude Gorin
    Bipin Savani
    Christoph Schmid
    Sally Wetten
    Mohamad Mohty
    Arnon Nagler
    Annals of Hematology, 2019, 98 : 2389 - 2398
  • [25] Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
    Giebel, Sebastian
    Boumendil, Ariane
    Labopin, Myriam
    Seesaghur, Anouchka
    Baron, Frederic
    Ciceri, Fabio
    Esteve, Jordi
    Gorin, Norbert-Claude
    Savani, Bipin
    Schmid, Christoph
    Wetten, Sally
    Mohty, Mohamad
    Nagler, Arnon
    ANNALS OF HEMATOLOGY, 2019, 98 (10) : 2389 - 2398
  • [26] Peripheral blood stem cell versus bone marrow transplantation: A perspective from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Byrne, Michael
    Savani, Bipin N.
    Mohty, Mohamad
    Nagler, Arnon
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (07) : 567 - 573
  • [27] Posttransplant cyclophosphamide versus antithymocyte globulin in patients with acute lymphoblastic leukemia treated with allogeneic hematopoietic cell transplantation from matched unrelated donors. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Giebel, Sebastian
    Labopin, Myriam
    Salmenniemi, Urpu
    Socie, Gerard
    Bondarenko, Sergey
    Blaise, Didier
    Kroeger, Nicolaus
    Vydra, Jan
    Grassi, Anna
    Bonifazi, Francesca
    Czerw, Tomasz
    Anagnostopoulos, Achilles
    Lioure, Bruno
    Ruggeri, Annalisa
    Savani, Bipin
    Spyridonidis, Alexandros
    Sanz, Jaime
    Peric, Zinaida
    Nagler, Arnon
    Ciceri, Fabio
    Mohty, Mohamad
    CANCER, 2023, 129 (23) : 3735 - 3745
  • [28] Allogeneic Hematopoietic Stem Cell Transplantation in Adolescent and Adult Patients with High-Risk T Cell Acute Lymphoblastic Leukemia
    Bakr, Mohammad
    Rasheed, Walid
    Mohamed, Said Y.
    Al-Mohareb, Fahad
    Chaudhri, Naeem
    Al-Sharif, Fahad
    Al-Zahrani, Hazza
    Al-Dawsari, Ghuzayel
    Saleh, Abu Jafar
    Nassar, Amr
    Ahmed, Shad
    Elghazaly, Assem
    Ahmed, Syed O.
    Ibrahim, Khalid
    Chebbo, Wahiba
    El Gohary, Ghada M.
    Al Mahayni, Muhamad H.
    Hussain, Fazal
    Nurgat, Zubeir
    Elhassan, Tusneem Ahmed
    Walter, Claudia U.
    Aljurf, Mahmoud
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (12) : 1897 - 1904
  • [29] Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Adolescents and Young Adults
    Hangai, Mayumi
    Urayama, Kevin Y.
    Tanaka, Junji
    Kato, Koji
    Nishiwaki, Satoshi
    Koh, Katsuyoshi
    Noguchi, Maiko
    Kato, Keisuke
    Yoshida, Nao
    Sato, Maho
    Goto, Hiroaki
    Yuza, Yuki
    Hashii, Yoshiko
    Atsuta, Yoshiko
    Mizuta, Shuichi
    Kato, Motohiro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (08) : 1597 - 1602
  • [30] Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia in the Modern Era
    Liang, Emily C.
    Craig, Juliana
    Torelli, Stefan
    Cunanan, Kristen
    Iglesias, Maria
    Arai, Sally
    Frank, Matthew J.
    Johnston, Laura
    Lowsky, Robert
    Meyer, Everett H.
    Miklos, David B.
    Negrin, Robert
    Rezvani, Andrew
    Shiraz, Parveen
    Shizuru, Judith
    Sidana, Surbhi
    Weng, Wen-Kai
    Bharadwaj, Sushma
    Muffly, Lori
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (08): : 490 - 495